中国组织工程研究与临床康复
中國組織工程研究與臨床康複
중국조직공정연구여림상강복
JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH
2010年
10期
1874-1877
,共4页
肝炎%疗效%肝功能%血象%输注%脐血
肝炎%療效%肝功能%血象%輸註%臍血
간염%료효%간공능%혈상%수주%제혈
背景:研究资料证明脐血干细胞移植能改善患者肝功能和免疫功能,修复肝损伤,促进肝细胞再生,但具体分化机制及生物学特性尚不明了,远期治疗前景有待分析.目的:对照分析脐血输注与血浆输注对慢性乙型重型肝炎患者的远期治疗效果.方法:2003-01/2004-01中南大学湘雅二医院住院的慢性重型肝炎患者50例,随机分为治疗组、对照组,25例/组,两组患者均接受护肝、对症、支持等综合治疗,在年龄、病情、用药等方面无明显差异,具有可比性.脐血来源干产前检查HBsAg、抗HCV、抗HIV、KT阴性,无血液病的健康足月顺产产妇,应用一次性采血袋,以封闭式采血法采血.脐血离心后,保留有核细胞及脐血浆,24 h内使用.治疗组输沣脐血干细胞悬液,200 mL/次,每周一两次,每例患者输注4~8次,平均5次;对照组输注成人新鲜血浆.检测两组患者治疗前后血象和肝功能各项指标的变化.结果与结论:两组患者全部完成1年随访.治疗前两组患者肝功能和血象各项指标均基本相似(P>0.05).脐血治疗1年后,两组患者血象各项指标无明显差异(P>0.05),但治疗组谷丙转氨酶、总胆红素明显低于对照组(P<0.05),血清白蛋白明显高于对照组(P<0.05).与治疗前比较,脐血治疗1年后治疗组血小板无明显变化,谷丙转氨酶、总胆红素均明显下降(P<0.05),血清白蛋白明显升高(P<0.05);对照组血小板明显下降(P<0.05),血清白蛋白明显下降(P<0.05).提示脐血输注可改善重型肝炎患者的肝功能和血象,可作为其辅助治疗措施.
揹景:研究資料證明臍血榦細胞移植能改善患者肝功能和免疫功能,脩複肝損傷,促進肝細胞再生,但具體分化機製及生物學特性尚不明瞭,遠期治療前景有待分析.目的:對照分析臍血輸註與血漿輸註對慢性乙型重型肝炎患者的遠期治療效果.方法:2003-01/2004-01中南大學湘雅二醫院住院的慢性重型肝炎患者50例,隨機分為治療組、對照組,25例/組,兩組患者均接受護肝、對癥、支持等綜閤治療,在年齡、病情、用藥等方麵無明顯差異,具有可比性.臍血來源榦產前檢查HBsAg、抗HCV、抗HIV、KT陰性,無血液病的健康足月順產產婦,應用一次性採血袋,以封閉式採血法採血.臍血離心後,保留有覈細胞及臍血漿,24 h內使用.治療組輸灃臍血榦細胞懸液,200 mL/次,每週一兩次,每例患者輸註4~8次,平均5次;對照組輸註成人新鮮血漿.檢測兩組患者治療前後血象和肝功能各項指標的變化.結果與結論:兩組患者全部完成1年隨訪.治療前兩組患者肝功能和血象各項指標均基本相似(P>0.05).臍血治療1年後,兩組患者血象各項指標無明顯差異(P>0.05),但治療組穀丙轉氨酶、總膽紅素明顯低于對照組(P<0.05),血清白蛋白明顯高于對照組(P<0.05).與治療前比較,臍血治療1年後治療組血小闆無明顯變化,穀丙轉氨酶、總膽紅素均明顯下降(P<0.05),血清白蛋白明顯升高(P<0.05);對照組血小闆明顯下降(P<0.05),血清白蛋白明顯下降(P<0.05).提示臍血輸註可改善重型肝炎患者的肝功能和血象,可作為其輔助治療措施.
배경:연구자료증명제혈간세포이식능개선환자간공능화면역공능,수복간손상,촉진간세포재생,단구체분화궤제급생물학특성상불명료,원기치료전경유대분석.목적:대조분석제혈수주여혈장수주대만성을형중형간염환자적원기치료효과.방법:2003-01/2004-01중남대학상아이의원주원적만성중형간염환자50례,수궤분위치료조、대조조,25례/조,량조환자균접수호간、대증、지지등종합치료,재년령、병정、용약등방면무명현차이,구유가비성.제혈래원간산전검사HBsAg、항HCV、항HIV、KT음성,무혈액병적건강족월순산산부,응용일차성채혈대,이봉폐식채혈법채혈.제혈리심후,보류유핵세포급제혈장,24 h내사용.치료조수풍제혈간세포현액,200 mL/차,매주일량차,매례환자수주4~8차,평균5차;대조조수주성인신선혈장.검측량조환자치료전후혈상화간공능각항지표적변화.결과여결론:량조환자전부완성1년수방.치료전량조환자간공능화혈상각항지표균기본상사(P>0.05).제혈치료1년후,량조환자혈상각항지표무명현차이(P>0.05),단치료조곡병전안매、총담홍소명현저우대조조(P<0.05),혈청백단백명현고우대조조(P<0.05).여치료전비교,제혈치료1년후치료조혈소판무명현변화,곡병전안매、총담홍소균명현하강(P<0.05),혈청백단백명현승고(P<0.05);대조조혈소판명현하강(P<0.05),혈청백단백명현하강(P<0.05).제시제혈수주가개선중형간염환자적간공능화혈상,가작위기보조치료조시.
BACKGROUND:Umbilical cord blood transplantation can ameliorate hepatic and immunologic function,repair hepatic injury,and promote hepatic regeneration,however,the differentiation mechanism and biological characteristics remain poorly understood,and the long-term efficiency need to be explored.OBJECTIVE:To investigate the long-term therapeutic efficacy of infusing umbilical cord blood and blood plasma in treating chronic severe hepatitis B patients.METHODS:Totally 50 chronic severe hepatitis B patients received treatment at the Second Xiangya Hospital,Central South University from January 2003 to January 2004 were randomly divided into the treatment and control groups,with 25 cases in each group.All patient were accepted an ordinary synthetic treatment,and the differences between age,pathogenetic condition,medication had no significance.The umbilical cord blood was obtained from healthy full-term spontaneous delivery parturient,centrifugated,remained karyotes and cord plasma,and used within 24 hours.Patients in the treatment group were received umbilical cord blood infusion,200 mL once,1 2 times per week,totally,each patients infused 4-8 times(mean 5 times);those in the control group were infused with adult fresh blood plasma.The changes of hemogram and hepatic function were measured.RESULTS AND CONCLUSION:All the patients were followed-up for 1 year.The hemogram and hepatic function indexes were similar in the 2 groups before treatment(P > 0.05).The hemogram index had no obviously difference at 1 year after treatment (P > 0.05),but the alanine aminotransferase and total bilirubin levels were decreased in the treatment compared with the control group(P < 0.05),but the albumin was significantly increased(P < 0.05).Compared with before treatment,the platelet level had no significant changes at 1 year after treatment,but the alanine aminotransferase and total bilirubin levels were deeply decreased(P< 0.05),albumin was significantly increased(P < 0.05);the platelet and albumin levels were dramatically decreased in the control group(P < 0.05).It suggested that umbilical cord blood infusion can improve the hepatic function and hemogram;therefore,it can be served as supplementary therapeutic measure for severe hepatitis.